UB Paderborn / Katalog / Suche / in CDI

DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy

Current cancer drug targets, 2010-11, Vol.10 (7), p.758

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Annals of oncology, 2017-02, Vol.28 (2), p.285-291

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-effective Approaches for Sustainable Groundwater Management in Alluvial Aquifer Systems

Water resources management, 2009, Vol.23 (2), p.219-233

2009

Link zum Volltext

Verfügbarkeit prüfen

Amrubicin (Amr) Versus Docetaxel (Dtx) As Second- or Third-Line Treatment for Non-Small Cell Lung Cancer (Nsclc): a Randomized Phase III Trial

Annals of oncology, 2014-09, Vol.25, p.iv432

2014

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest

Leukemia, 2006-10, Vol.20 (10), p.1809-1818

2006

Link zum Volltext

Verfügbarkeit prüfen

Reflections on a mutual journey of discovery and growth based on a Japanese-South African collaboration

Professional development in education, 2011-07, Vol.37 (3), p.335-352

2011

Link zum Volltext

Verfügbarkeit prüfen

383MO Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping

Annals of oncology, 2020-11, Vol.31, p.S1390-S1391

2020

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Chest, 2019-08, Vol.156 (2), p.357-366

2019

Link zum Volltext

Verfügbarkeit prüfen

Determination of hydraulic parameters of an unconfined alluvial aquifer by the floodwave-response technique

Hydrogeology journal, 2004-12, Vol.12 (6), p.628-642

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild-type EGFR: The Okayama Lung Cancer Study Group Trial 1202 (OLCSG1202)

Annals of oncology, 2017-11, Vol.28, p.x139-x140

2017

Link zum Volltext

Verfügbarkeit prüfen

On the estimation of phreatic aquifer parameters by the tidal response technique

Water resources management, 2003-02, Vol.17 (1), p.69-88

2003

Link zum Volltext

Verfügbarkeit prüfen

A Phase Ii Trial of Gefitinib in Combination with Bevacizumab As First-Line Therapy for Advanced Non-Small-Cell Lung Cancer with Activating Egfr Gene Mutations: Olcsg 1001

Annals of oncology, 2014-09, Vol.25, p.iv452

2014

Link zum Volltext

Verfügbarkeit prüfen

Field investigations for sustainable groundwater utilization in the Konan basin

Water resources management, 1999-12, Vol.13 (6), p.443-470

1999

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Erlotinib as First-Line Treatment in Japanese Advanced NSCLC Patients Harboring EGFR Mutations

Annals of oncology, 2012-09, Vol.23, p.ix413

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective Evaluation of the Effect of a Manual for Diabetic Patients who Receive Cancer Chemotherapy

Annals of oncology, 2012-09, Vol.23, p.ix527

2012

Link zum Volltext

Verfügbarkeit prüfen

1705 - Prospective Evaluation of the Effect of a Manual for Diabetic Patients who Receive Cancer Chemotherapy

Annals of oncology, 2012-09, Vol.23, p.ix527-ix527

2012

Link zum Volltext

Verfügbarkeit prüfen

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

British journal of cancer, 1999-02, Vol.79 (5-6), p.984-990

1999

Link zum Volltext

Verfügbarkeit prüfen

Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?

Acta medica Okayama, 2011-08, Vol.65 (4), p.259-263

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7054-7054

2010

Link zum Volltext

Verfügbarkeit prüfen

Sensitization of DNA damage–induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3σ and survivin

Molecular cancer therapeutics, 2005-12, Vol.4 (12), p.1880-1890

2005

Link zum Volltext

Verfügbarkeit prüfen

Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure

Clinical chemistry (Baltimore, Md.), 1996-10, Vol.42 (10), p.1616-1620

1996

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity

The Journal of biological chemistry, 2003-04, Vol.278 (15), p.12696-12702

2003

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Effects of Topoisomerase I Inhibitor, 7-ethyl-10-hydroxycamptothecin, and Irradiation in a Cisplatin-resistant Human Small Cell Lung Cancer Cell Line

Clinical cancer research, 2002-01, Vol.8 (1), p.287-292

2002

Link zum Volltext

Verfügbarkeit prüfen

Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment

Oncology reports, 1999-01, Vol.6 (1), p.75

1999

Link zum Volltext

Verfügbarkeit prüfen

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

Lung cancer (Amsterdam, Netherlands), 2002-03, Vol.35 (3), p.305-314

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Cost-effective Approaches for Sustainable Groundwater Management in Alluvial Aquifer Systems

Amrubicin (Amr) Versus Docetaxel (Dtx) As Second- or Third-Line Treatment for Non-Small Cell Lung Cancer (Nsclc): a Randomized Phase III Trial

Downregulation of topoisomerase IIβ in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest

Reflections on a mutual journey of discovery and growth based on a Japanese-South African collaboration

383MO Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Determination of hydraulic parameters of an unconfined alluvial aquifer by the floodwave-response technique

A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small cell lung cancer with wild-type EGFR: The Okayama Lung Cancer Study Group Trial 1202 (OLCSG1202)

On the estimation of phreatic aquifer parameters by the tidal response technique

A Phase Ii Trial of Gefitinib in Combination with Bevacizumab As First-Line Therapy for Advanced Non-Small-Cell Lung Cancer with Activating Egfr Gene Mutations: Olcsg 1001

Field investigations for sustainable groundwater utilization in the Konan basin

A Phase II Study of Erlotinib as First-Line Treatment in Japanese Advanced NSCLC Patients Harboring EGFR Mutations

Prospective Evaluation of the Effect of a Manual for Diabetic Patients who Receive Cancer Chemotherapy

1705 - Prospective Evaluation of the Effect of a Manual for Diabetic Patients who Receive Cancer Chemotherapy

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?

A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC)

Sensitization of DNA damage–induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3σ and survivin

Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure

Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity

Synergistic Effects of Topoisomerase I Inhibitor, 7-ethyl-10-hydroxycamptothecin, and Irradiation in a Cisplatin-resistant Human Small Cell Lung Cancer Cell Line

Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

Suchergebnisse filtern